123 related articles for article (PubMed ID: 31609759)
1. Matrine enhances the efficacy of adriamycin chemotherapy in osteosarcoma cells by the STAT3 pathway.
Zhou H; Chen S; Yang Y; Yang C; Chen D; Yao Z; Sun B
Anticancer Drugs; 2019 Nov; 30(10):1006-1012. PubMed ID: 31609759
[TBL] [Abstract][Full Text] [Related]
2. Matrine inhibits the invasive properties of human osteosarcoma cells by downregulating the ERK-NF-κB pathway.
Li Y; Zhang ZN; Zhao HM; Tong ZC; Yang J; Wang H; Liang XJ
Anticancer Drugs; 2014 Oct; 25(9):1035-43. PubMed ID: 24999836
[TBL] [Abstract][Full Text] [Related]
3. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Liang CZ; Zhang JK; Shi Z; Liu B; Shen CQ; Tao HM
Cancer Chemother Pharmacol; 2012 Feb; 69(2):317-31. PubMed ID: 21717192
[TBL] [Abstract][Full Text] [Related]
4. Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway.
Huang H; Du T; Xu G; Lai Y; Fan X; Chen X; Li W; Yue F; Li Q; Liu L; Li K
Int J Oncol; 2017 Feb; 50(2):640-648. PubMed ID: 28000853
[TBL] [Abstract][Full Text] [Related]
5. Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.
Xu GP; Zhao W; Zhuang JP; Zu JN; Wang DY; Han F; Zhang ZP; Yan JL
Tumour Biol; 2015 Mar; 36(3):1653-9. PubMed ID: 25371071
[TBL] [Abstract][Full Text] [Related]
6. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
[TBL] [Abstract][Full Text] [Related]
7. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
9. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
Ji XL; He M
Aging (Albany NY); 2019 Aug; 11(15):5848-5863. PubMed ID: 31422383
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
[TBL] [Abstract][Full Text] [Related]
11. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway.
Yan F; Liu Y; Wang W
Tumour Biol; 2013 Aug; 34(4):2135-40. PubMed ID: 23589054
[TBL] [Abstract][Full Text] [Related]
12. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
Miao J; Chen S; Cao H; Ding Z; Li Y; Wang W; Nundlall K; Deng Y; Li J
Mol Carcinog; 2024 Jun; 63(6):1133-1145. PubMed ID: 38426797
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
Xian M; Cao H; Cao J; Shao X; Zhu D; Zhang N; Huang P; Li W; Yang B; Ying M; He Q
Int J Cancer; 2017 Sep; 141(5):1029-1041. PubMed ID: 28524233
[TBL] [Abstract][Full Text] [Related]
14. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
[TBL] [Abstract][Full Text] [Related]
16. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
[TBL] [Abstract][Full Text] [Related]
17. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
[TBL] [Abstract][Full Text] [Related]
18. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
[TBL] [Abstract][Full Text] [Related]
19. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Li Y; Xian M; Yang B; Ying M; He Q
Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]